(603367)"Cisen Pharmaceutical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 603367 · · 18 pages · Chinese
Cisen Pharmaceutical Ltd. on 6ix
Earlier from Cisen Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on a Subsidiary's Receipt of the First Generic Approval for Marketing of Its Loteprednol Etabonate and Tobramycin Eye Drops
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Outline of the 2026 Semi-annual Performance and Cash Dividend Briefing
- Notice on Convening the 1st Extraordinary General Meeting in 2026
Follow Cisen Pharmaceutical into a list and get an email when it puts out news.
Follow Cisen Pharmaceutical